Form 8-K - Current report:
SEC Accession No. 0001104659-24-114101
Filing Date
2024-11-05
Accepted
2024-11-05 07:40:12
Documents
15
Period of Report
2024-11-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2427489d1_8k.htm   iXBRL 8-K 31756
2 EXHIBIT 99.1 tm2427489d1_ex99-1.htm EX-99.1 18429
6 GRAPHIC tm2427489d1_ex99-1img001.jpg GRAPHIC 25690
  Complete submission text file 0001104659-24-114101.txt   267337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ogn-20241105.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20241105_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20241105_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2427489d1_8k_htm.xml XML 3684
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 241425646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)